All > Probuphine

Contingency Management for Stimulant Use Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Minnesota, Minneapolis, MNStimulant Use Disorder+1 MoreContingency Management - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a contingency management program for patients with opioid use disorder starting outpatient addiction medicine services. The goal is to improve patient outcomes and treatment retention.

Eligible Conditions
  • Stimulant Use Disorder
  • Opioid Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Prize-Based Contingency Management
1
Contingency Management
1
App-Based Contingency Management

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 30 days post-intervention

30 days post-intervention
Feasibility of CM for OUD in primary care: Recruitment
Feasibility of CM for OUD in primary care: Retention
Preliminary efficacy of CM on clinical outcomes: Urine toxicology
Preliminary efficacy of CM on clinical outcomes: Visit Frequency

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Prize-Based Contingency Management
2
Contingency Management
2
App-Based Contingency Management

Trial Design

3 Treatment Groups

Treatment as usual (TAU)
1 of 3
Attendance-only CM
1 of 3
Attendance + abstinence CM
1 of 3

Active Control

Experimental Treatment

200 Total Participants · 3 Treatment Groups

Primary Treatment: Contingency Management · No Placebo Group · N/A

Attendance-only CM
Behavioral
Experimental Group · 1 Intervention: Contingency Management · Intervention Types: Behavioral
Attendance + abstinence CM
Behavioral
Experimental Group · 1 Intervention: Contingency Management · Intervention Types: Behavioral
Treatment as usual (TAU)NoIntervention Group · 1 Intervention: Treatment as usual (TAU) · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2003
Completed Phase 2
~3230

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days post-intervention

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,271 Previous Clinical Trials
1,487,792 Total Patients Enrolled
Robert Levy, MDPrincipal InvestigatorUniversity of Minnesota
4 Previous Clinical Trials
143 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with addiction to opioids or stimulants.
References

Frequently Asked Questions

Are there any volunteers being welcomed into the research project at this time?

"Affirmative. Clinicaltrials.gov records demonstrate that this trial, which initially went public on June 15th 2022, is actively recruiting participants; 200 individuals will be enrolled at one medical site in total." - Anonymous Online Contributor

Unverified Answer

What is the current participation rate for this clinical experiment?

"Affirmative, clinicaltrials.gov exhibits that this trial is actively recruiting patients since its inception on June 15th 2022 and the most recent update also indicates that 200 individuals will be recruited from one location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top